Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2014-11-20 17:19:13
Reporting Period:
Filing Date:
Accepted Time:
2014-11-20 17:19:13
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1022079 Quest Diagnostics Inc DGX Services-Medical Laboratories (8071) 161387862
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1222675 F Thomas Bongiorno C/o Quest Diagnostics Incorporated
3 Giralda Farms
Madison NJ 07940
Vp And Corporate Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-18 10,000 $47.49 25,187 No 4 M Direct
Common Stock Disposition 2014-11-18 10,000 $64.00 15,377 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2014-11-18 10,000 $0.00 10,000 $47.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-03-04 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,150 Indirect 401(k)
  1. The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
  2. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
  3. The options vested in three equal annual installments beginning with the first on March 4, 2009, the second on March 4, 2010, and the final on March 4, 2011.